title: Chemotherapy in biliary tract carcinomas: results in India.
abstract: Epidemiology data from India suggest that biliary tract carcinomas occur primarily in the older population. Because of the absence of early symptoms, most patients present with advanced disease, and the outcome has been disappointing even in patients with resectable tumors who have undergone aggressive surgery. Although there is no standard therapy, data from recent clinical trials warrant further investigation of the role of chemotherapy in biliary tract carcinoma. In view of the favorable toxicity profile and observed efficacy of gemcitabine in advanced biliary tract cancers, its evaluation in combination with other active, potentially synergistic cytotoxic drugs such as cisplatin, capecitabine, and carboplatin should be studied with an aim to improve therapeutic efficacy and survival.
authors.affiliation: Rajiv Gandhi Cancer Institute, New Delhi, India.
authors.forename: Dinesh C
authors.initials: DC
authors.lastname: Doval
authors.forename: Jagdev S
authors.initials: JS
authors.lastname: Sekhon
authors.forename: Sunil K
authors.initials: SK
authors.lastname: Gupta
authors.forename: Sanjay
authors.initials: S
authors.lastname: Gupta
authors.forename: Bhawana S
authors.initials: BS
authors.lastname: Awasthy
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001661:Biliary Tract Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007194:India / Q000453:epidemiology; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine